Search For "liver disease"
Zydus and Lupin Sign Licensing Agreement for Co-Marketing Saroglitazar Mg,
Updated : 2 years, 4 months ago IST
Ahmedabad (Gujarat) [India], November 3: Zydus Lifesciences Limited (including its subsidiaries/affiliates hereafter referred to as "Zydus") a discovery-driven, global lifesciences company and Lupin Limited (Lupin), a global pharma major, today announced that they have entered into a licensi
Read More
Study indicates how resistant starch consumption decreases liver triglycer
Updated : 5 months, 1 week ago IST
Resistant starch is a nondigestible fibre that ferments in the large intestine and has previously been found to boost metabolism in animal tests. A 4-month randomised controlled experiment in persons with non-alcoholic fatty liver disease (NAFLD) found that regularly eating resistant starch
Read More
Study reveals how resistant starch intake lowers liver triglycerides in pe
Updated : 5 months, 1 week ago IST
Resistant starch is a nondigestible fibre that ferments in the large intestine and has previously been shown in animal studies to improve metabolism.
Read More
Liver cancer more common if close relative has fatty liver disease
Updated : 5 months, 1 week ago IST
According to a national study published in The Journal of Hepatology, close relatives of persons with metabolic-associated fatty liver disease had a greater chance of acquiring liver cancer and dying from liver-related disorders. According to the researchers, this suggests that family member
Read More
Race, ethnicity variances may cause liver cancer: Study
Updated : 5 months, 1 week ago IST
A recent study of liver cancer found racial and ethnic variances as well as developing patterns in this deadly disease. The study also identified potential focused therapies to increase control and prevention.
Read More
Study finds how intake of resistant starch reduces liver triglycerides in
Updated : 2 years, 6 months ago IST
Resistant starch is a nondigestible fibre that ferments in the large intestine, and it has previously been demonstrated in animal experiments to have a favourable effect on metabolism. A 4-month randomised controlled experiment in persons with non-alcoholic fatty liver disease (NAFLD) has fo
Read More
Study finds how high drug price linked with decreased treatment retention
Updated : 2 years, 6 months ago IST
High expenditures for treating hepatic encephalopathy in people with end-stage liver disease were linked to worse patient adherence to therapy, according to research from the University of Minnesota Medical School and College of Pharmacy.
Read More
Noted Malayalam filmmaker Siddique passes away, condolences pour in
Updated : 2 years, 7 months ago IST
The renowned filmmaker and screenwriter was admitted to Amrita Hospital with chronic liver disease and bronchopneumonia.
Read More
Gastroenterology Excellence Personified: Four renowned doctors unite at Ve
Updated : 2 years, 8 months ago IST
New Delhi [India], July 6: Vedam Gastro Hospital, one of the best gastro hospitals in Surat, is proud to announce the collaboration of four renowned gastroenterologists, Dr Pallav Parikh, Dr Pravin Borasadia, Dr Ronak Malani, and Dr Pintu Bhakhar. With a combined experience of 30 years and a
Read More
Prevalence of metabolically related fatty liver disease is rising: Study
Updated : 2 years, 8 months ago IST
According to a study presented at the Endocrine Society's annual meeting in Chicago, the percentage of adults suffering from metabolic-associated fatty liver disease (MAFLD), the leading cause of liver disease worldwide, is increasing.
Read More
Study reveals prevalence of metabolically related fatty liver disease is r
Updated : 2 years, 8 months ago IST
According to a study presented at ENDO 2023, the Endocrine Society's annual meeting in Chicago, the percentage of adults with metabolic-associated fatty liver disease (MAFLD), the major global cause of liver disease, is growing.
Read More
Study finds how prevalence of metabolic linked to fatty liver disease is i
Updated : 2 years, 9 months ago IST
According to a study presented Friday at ENDO 2023, the Endocrine Society's annual meeting in Chicago, the percentage of adults with metabolic-associated fatty liver disease (MAFLD), the major global cause of liver disease, is growing.
Read More